The FDA is reportedly facing internal instability and external pressure, with some outlets suggesting that commissioner Marty Makary is struggling to stabilize the agency. However, there are conflicting reports about Makary's status, with some indicating he has resigned and others stating he is being fired. The agency is also dealing with regulatory issues and concerns, including a new expedited drug program and potential staff departures.